A citation-based method for searching scientific literature

Moshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, John P Ray, Carl G de Boer, Russell W Jenkins, David J Lieb, Jonathan H Chen, Dennie T Frederick, Michal Barzily-Rokni, Samuel S Freeman, Alexandre Reuben, Paul J Hoover, Alexandra-Chlo√© Villani, Elena Ivanova, Andrew Portell, Patrick H Lizotte, Amir R Aref, Jean-Pierre Eliane, Marc R Hammond, Hans Vitzthum, Shauna M Blackmon, Bo Li, Vancheswaran Gopalakrishnan, Sangeetha M Reddy, Zachary A Cooper, Cloud P Paweletz, David A Barbie, Anat Stemmer-Rachamimov, Keith T Flaherty, Jennifer A Wargo, Genevieve M Boland, Ryan J Sullivan, Gad Getz, Nir Hacohen. Cell 2018
Times Cited: 448



Naiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa S Ho, Martin L Miller, Natasha Rekhtman, Andre L Moreira, Fawzia Ibrahim, Cameron Bruggeman, Billel Gasmi, Roberta Zappasodi, Yuka Maeda, Chris Sander, Edward B Garon, Taha Merghoub, Jedd D Wolchok, Ton N Schumacher, Timothy A Chan. Science 2015
Times Cited: 4404




List of shared articles



Times cited

Tumor-infiltrating lymphocytes in the immunotherapy era.
Sterre T Paijens, Anneg√© Vledder, Marco de Bruyn, Hans W Nijman. Cell Mol Immunol 2021
24


Understanding the tumor microenvironment for effective immunotherapy.
Habib Sadeghi Rad, James Monkman, Majid E Warkiani, Rahul Ladwa, Ken O'Byrne, Nima Rezaei, Arutha Kulasinghe. Med Res Rev 2021
8

Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1.
Zi Yin, Min Yu, Tingting Ma, Chuanzhao Zhang, Shanzhou Huang, Mohammad Reza Karimzadeh, Amir Abaas Momtazi-Borojeni, Sheng Chen. J Immunother Cancer 2021
10

Intratumoral heterogeneity in cancer progression and response to immunotherapy.
Ilio Vitale, Efrat Shema, Sherene Loi, Lorenzo Galluzzi. Nat Med 2021
33

Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma.
Zoe C Schmiechen, Ingunn M Stromnes. Front Immunol 2021
2

Impact of cancer evolution on immune surveillance and checkpoint inhibitor response.
Yin Wu, Dhruva Biswas, Charles Swanton. Semin Cancer Biol 2021
3

Advanced Melanoma: Resistance Mechanisms to Current Therapies.
Alexandra M Haugh, April K S Salama, Douglas B Johnson. Hematol Oncol Clin North Am 2021
0

Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade.
Yanna Lei, Xiaoying Li, Qian Huang, Xiufeng Zheng, Ming Liu. Front Oncol 2021
3

Predictive biomarkers for response to immune checkpoint inhibition.
Benjamin Shum, James Larkin, Samra Turajlic. Semin Cancer Biol 2021
7